Date: TBD

According to the CDC, millions of US children have been diagnosed with ADHD. The estimated number of children aged 3–17 years diagnosed with ADHD (a national survey of parents) is 6 million or 9.8% using data from 2016-2019. Boys (13%) are more likely to be diagnosed with ADHD than girls (6%). About 3 in 4 US children with current ADHD receive treatment. Specifically, 62% were taking ADHD medication. What are the pros and cons of addressing ADHD through pharmaceutical remedies? Are there risks of prolonged use? If so, how does it compare to the risks of foregoing the many pharmaceutical remedies?

Moderators:

Athena Goldstein and Kristen Koh Goldstein

Panelists:

Jack Goldstein, Co-Founder of JAR Farms. Diagnosed with ADHD at age 5, Jack struggled with the debilitating cycle of ADHD medication causing insomnia, and the insomnia medication in turn causing drowsiness. After several years of chronic sleep deprivation and stumbling through the day in a fog, Jack experienced a mental health crisis.

Mark Goldstein, Managing Partner, Advisors Fund. Mark has evaluated a number of digital health startups on a mission to help those with ADHD.

Kim Norman MD, Distinguished Professor, UCSF Weill Institute for Neurosciences

Jesse Woods, Facilities Manager of JAR Farms. Jesse felt like a zombie until he learned how to manage his ADHD without stimulants and melatonin. While Jesse is not a lawyer or doctor like his uncles, he is happy working with his hands every day.